Related Experiment Video
Updated: May 3, 2026

05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
11.1K
Blunted inflammatory response in STEMI patients timely reperfused
Natale Daniele Brunetti1, Michele Correale, Luisa De Gennaro
1Cardiology Department, University of Foggia, Foggia, Italy.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|February 5, 2014
Summary
Timely reperfusion in ST-elevation myocardial infarction (STEMI) significantly reduces systemic inflammation markers like CRP. This intervention blunts the inflammatory response compared to delayed treatment.
Area of Science:
- Cardiology
- Biomedical Science
- Inflammation Research
Background:
- Acute coronary syndrome involves a significant systemic inflammatory response.
- Investigating the impact of reperfusion timing on inflammation in STEMI patients is crucial.
Purpose of the Study:
- To determine if prompt reperfusion therapy can mitigate the inflammatory response in ST-elevation myocardial infarction (STEMI) patients.
- To compare inflammatory markers between patients receiving timely reperfusion and those with delayed treatment.
Main Methods:
- Forty-seven STEMI patients received timely reperfusion with tenecteplase.
- Thirty-three late-presenting patients undergoing delayed angioplasty served as controls.
- Serial blood samples measured C-reactive protein (CRP), fibrinogen, and erythrocyte sedimentation rate (ESR) over 4 days.
Main Results:
- Timely reperfused patients exhibited significantly lower CRP, ESR, and fibrinogen levels than late-comer controls.
- Multivariable analysis confirmed timely reperfusion inversely correlated with peak CRP values (HR 0.74, P<0.05).
Conclusions:
- Prompt reperfusion therapy effectively reduces systemic inflammatory activation in STEMI patients.
- Early intervention is key to blunting the inflammatory cascade post-myocardial infarction.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K

